ID

13021

Beschreibung

Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00275015

Link

https://clinicaltrials.gov/show/NCT00275015

Stichworte

  1. 12.01.16 12.01.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

12. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Leukemia NCT00275015

Eligibility Leukemia NCT00275015

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00275015
Criteria
Beschreibung

Criteria

patients with chronic lymphocytic leukemia, meeting 1 of the following criteria:
Beschreibung

CLL

Datentyp

boolean

Alias
UMLS CUI [1]
C0023434
binet stage b or c disease
Beschreibung

binet stage

Datentyp

boolean

Alias
UMLS CUI [1]
C1511118
binet stage a disease and at high risk for disease progression, defined as the following:
Beschreibung

binet stage a disease and at high risk for disease progression

Datentyp

boolean

Alias
UMLS CUI [1]
C1511118
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
Beschreibung

non-nodular marrow infiltration or lymphocyte doubling time < 12 months

Datentyp

boolean

Alias
UMLS CUI [1]
C3854434
UMLS CUI [2]
C2986483
thymidine kinase > 7.0 u/l or ß-2-microglobulin > 3.5 mg/l
Beschreibung

thymidine kinase, ß-2-microglobulin

Datentyp

boolean

Alias
UMLS CUI [1]
C0040078
UMLS CUI [2]
C0005149
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
Beschreibung

polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h

Datentyp

boolean

Alias
UMLS CUI [1]
C0887928
ecog performance status 0-1
Beschreibung

ecog performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
no concurrent disease resulting in major organ dysfunction
Beschreibung

no concurrent disease resulting in major organ dysfunction

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
Beschreibung

no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)

Datentyp

boolean

Alias
UMLS CUI [1]
C0025241
UMLS CUI [2]
C0011777
UMLS CUI [3]
C0007257
UMLS CUI [4]
C0010711
UMLS CUI [5]
C0015133
no more than 1 prior chemotherapy regimen
Beschreibung

no more than 1 prior chemotherapy regimen

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
no prior chemotherapy regimen longer than 6 months in duration
Beschreibung

no prior chemotherapy regimen longer than 6 months in duration

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920

Ähnliche Modelle

Eligibility Leukemia NCT00275015

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00275015
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
CLL
Item
patients with chronic lymphocytic leukemia, meeting 1 of the following criteria:
boolean
C0023434 (UMLS CUI [1])
binet stage
Item
binet stage b or c disease
boolean
C1511118 (UMLS CUI [1])
binet stage a disease and at high risk for disease progression
Item
binet stage a disease and at high risk for disease progression, defined as the following:
boolean
C1511118 (UMLS CUI [1])
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
Item
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
boolean
C3854434 (UMLS CUI [1])
C2986483 (UMLS CUI [2])
thymidine kinase, ß-2-microglobulin
Item
thymidine kinase > 7.0 u/l or ß-2-microglobulin > 3.5 mg/l
boolean
C0040078 (UMLS CUI [1])
C0005149 (UMLS CUI [2])
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
Item
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
boolean
C0887928 (UMLS CUI [1])
ecog performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
no concurrent disease resulting in major organ dysfunction
Item
no concurrent disease resulting in major organ dysfunction
boolean
C0009488 (UMLS CUI [1])
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
Item
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
boolean
C0025241 (UMLS CUI [1])
C0011777 (UMLS CUI [2])
C0007257 (UMLS CUI [3])
C0010711 (UMLS CUI [4])
C0015133 (UMLS CUI [5])
no more than 1 prior chemotherapy regimen
Item
no more than 1 prior chemotherapy regimen
boolean
C0392920 (UMLS CUI [1])
no prior chemotherapy regimen longer than 6 months in duration
Item
no prior chemotherapy regimen longer than 6 months in duration
boolean
C0392920 (UMLS CUI [1])

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video